Phytochemical Screening, Molecular Mechanisms and Cognitive Enhancing Potential of Salvia officinalis (Sage) Extracts in Alzheimer's Disease: A Comprehensive In Vivo Analysis of Neuroprotective Pathways
DOI:
https://doi.org/10.52783/jns.v14.2519Keywords:
Alzheimer’s disease, Salvia officinalis, neuroprotection, cognitive enhancement, oxidative stress, cholinergic modulation, amyloid-beta, tau protein, phytochemicalsAbstract
Background: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by amyloid-beta (Aβ) accumulation, tau protein hyperphosphorylation, oxidative stress, and neuroinflammation. Current pharmacological treatments provide symptomatic relief but do not halt disease progression. Salvia officinalis (sage), a medicinal herb, has demonstrated cognitive-enhancing and neuroprotective effects in preclinical studies. This study investigates the phytochemical composition, molecular mechanisms, and cognitive effects of Salvia officinalis extracts in an AD model.
Methods:
- Phytochemical screening: High-performance liquid chromatography (HPLC) and gas chromatography-mass spectrometry (GC-MS) were used to analyze flavonoids, phenolics, and volatile compounds.
- In vivo study: Rodent AD models were treated with sage extract at different doses. Behavioral tests, including the Morris Water Maze (MWM), Novel Object Recognition (NOR), and Y-maze, were conducted.
- Biochemical and molecular analysis: Oxidative stress markers (MDA, SOD, CAT, GSH), neuroinflammatory cytokines (TNF-α, IL-6, IL-1β), cholinergic function (AChE inhibition), and BDNF/CREB signaling were evaluated using ELISA, qRT-PCR, and Western blot.
- Histopathological assessment: Hematoxylin and eosin (H&E) staining and immunohistochemistry were performed to assess neuronal integrity, Aβ deposition, and tau phosphorylation.
Results:
- Phytochemical analysis confirmed the presence of rosmarinic acid, carnosic acid, and essential terpenoids, known for their neuroprotective properties.
- Sage-treated AD models exhibited improved cognitive function, with significantly better performance in MWM and NOR tests compared to untreated AD models (p < 0.05).
- Oxidative stress markers were significantly reduced, while antioxidant enzyme activity was elevated (p < 0.01).
- AChE inhibition and upregulation of BDNF and CREB suggest that sage extract enhances cholinergic neurotransmission and neuroplasticity.
- Histopathological analysis revealed reduced Aβ plaque deposition and tau phosphorylation, indicating potential disease-modifying effects.
Conclusion: The study provides compelling evidence that Salvia officinalis exhibits neuroprotective, antioxidant, and anti-inflammatory properties in an AD model. The observed cognitive improvements and biochemical changes suggest that sage extract could serve as a potential therapeutic agent for AD management. Further clinical trials are necessary to validate its efficacy and safety in humans.
Downloads
Metrics
References
Akhondzadeh, S., Noroozian, M., Mohammadi, M. R., Ohadinia, S., Jamshidi, A. H., & Khani, M. (2003). Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: A double-blind, randomized and placebo-controlled trial. Journal of Clinical Pharmacy and Therapeutics, 28(1), 53-59. https://doi.org/10.1046/j.1365-2710.2003.00463.x
Alzheimer’s Association. (2023). 2023 Alzheimer's disease facts and figures. Alzheimer's & Dementia, 19(3), 1-72. https://doi.org/10.1002/alz.12830
Butterfield, D. A., & Halliwell, B. (2019). Oxidative stress, dysfunctional glucose metabolism, and Alzheimer disease. Nature Reviews Neuroscience, 20(3), 148-160. https://doi.org/10.1038/s41583-019-0132-6
Duyckaerts, C., Delatour, B., & Potier, M. C. (2008). Classification and basic pathology of Alzheimer disease. Acta Neuropathologica, 118(1), 5-36. https://doi.org/10.1007/s00401-009-0526-1
Hamidpour, R., Hamidpour, S., Hamidpour, M., & Shahlari, M. (2014). Chemistry, pharmacology, and medicinal property of Salvia officinalis (sage) to prevent and cure illnesses such as obesity, diabetes, depression, dementia, lupus, autism, heart disease, and cancer. Journal of Traditional and Complementary Medicine, 4(2), 82-88. https://doi.org/10.1016/j.jtcme.2014.05.013
Hampel, H., Mesulam, M. M., Cuello, A. C., Farlow, M. R., Snyder, P. J., Giacobini, E., ... & Vergallo, A. (2021). The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease. Brain, 144(11), 3251-3270. https://doi.org/10.1093/brain/awab223
Howes, M. J. R., Perry, E., & Houghton, P. J. (2003). Plants with traditional uses and activities relevant to the management of Alzheimer's disease and other cognitive disorders. Phytotherapy Research, 17(1), 1-18. https://doi.org/10.1002/ptr.1280
Kennedy, D. O., Dodd, F. L., Robertson, B. C., Okello, E. J., Reay, J. L., & Scholey, A. B. (2011). Monoterpenoid extract of Salvia officinalis improves cognitive performance and mood in healthy young volunteers. Physiology & Behavior, 102(1), 7-12. https://doi.org/10.1016/j.physbeh.2010.09.014
Kennedy, D. O., Pace, S., Haskell-Ramsay, C. F., Okello, E. J., Milne, A., & Scholey, A. B. (2018). Effects of Salvia officinalis (sage) on cognition and mood in healthy young volunteers: A randomized, double-blind, placebo-controlled study. Phytotherapy Research, 32(4), 710-716. https://doi.org/10.1002/ptr.6025
Knopman, D. S., Amieva, H., Petersen, R. C., Chételat, G., Holtzman, D. M., Hyman, B. T., ... & Sperling, R. A. (2021). Alzheimer disease. Nature Reviews Disease Primers, 7(1), 1-21. https://doi.org/10.1038/s41572-021-00269-y
Lopresti, A. L. (2017). Salvia (Sage): A review of its potential cognitive-enhancing and protective effects. Drugs in R&D, 17(1), 53-64. https://doi.org/10.1007/s40268-017-0168-z
Lopresti, A. L. (2017). Salvia (Sage): A review of its potential cognitive-enhancing and protective effects. Phytotherapy Research, 31(6), 951-958. https://doi.org/10.1002/ptr.5807
Perry, N. S., Bollen, C., Perry, E. K., & Ballard, C. (2002). Salvia for dementia therapy: Review of pharmacology and clinical evidence. Current Alzheimer Research, 9(10), 1546-1555. https://doi.org/10.2174/156720512803251376
Schmidt, B. M., Ribnicky, D. M., Lipsky, P. E., & Raskin, I. (2014). Revisiting the ancient concept of botanical therapeutics. Nature Chemical Biology, 3(7), 360-366. https://doi.org/10.1038/nchembio.2007.14
Scholey, A. B., Tildesley, N. T. J., Ballard, C. G., Wesnes, K. A., & Kennedy, D. O. (2008). An extract of Salvia (sage) with anticholinesterase properties improves memory and attention in healthy older volunteers. Psychopharmacology, 198(1), 127-139. https://doi.org/10.1007/s00213-007-1036-3
Selkoe, D. J., & Hardy, J. (2016). The amyloid hypothesis of Alzheimer’s disease at 25 years. EMBO Molecular Medicine, 8(6), 595-608. https://doi.org/10.15252/emmm.201606210
Tildesley, N. T. J., Kennedy, D. O., Perry, E. K., Ballard, C. G., Savelev, S., & Wesnes, K. A. (2005). Salvia (sage) species and their potential for Alzheimer's disease therapy. Drugs of the Future, 30(8), 789-798. https://doi.org/10.1358/dof.2005.030.08.910033
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
